Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2000 Apr;21(4):697-701.

Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging

Affiliations
Comparative Study

Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging

M Hutchinson et al. AJNR Am J Neuroradiol. 2000 Apr.

Abstract

Background and purpose: The possibility of using MR imaging as a sensitive marker of the structural changes in Parkinson's disease has been a long-sought goal. We describe a new method for imaging and quantifying the morphologic changes of the substantia nigra in Parkinson's disease and compare radiologic findings with clinical evaluation.

Methods: Using a combination of two MR imaging inversion-recovery pulse sequences, the substantia nigra was imaged in six patients with Parkinson's disease and six age-related control participants. A radiologic index was defined and used to quantify the signal changes that were observed in the patients. The radiologic index was compared with clinical scores obtained from the Unified Parkinson's Disease Rating Scale.

Results: The images showed loss of signal in a lateral-to-medial gradient in cases of Parkinson's disease, corresponding to the known neuropathologic pattern of degeneration. The radiologic index was highly correlated with the Unified Parkinson's Disease Rating Scale score, and there was no overlap in radiologic indices between the patient and the control groups (P < .00005).

Conclusion: This study suggests that MR imaging is sensitive to structural changes in even the earliest cases of Parkinson's disease, thereby indicating the potential for detecting presymptomatic disease. Furthermore, a radiologic measure has been defined that correlates with the conventional clinical measure of disease severity. Therefore, MR imaging could prove to be a sensitive biological marker for objective staging of the disease.

PubMed Disclaimer

Figures

<sc>fig</sc> 1.
fig 1.
Upper row displays an example of axial WMS and GMS MR acquisition images of the mesencephalon in a control participant. The cerebral peduncle (second row, left) extracted from the WMS midbrain image serves as a template to extract the GMS image of the cerebral peduncle shown on the right. The SNC is seen as a bright arch in the peduncular WMS image, whereas it appears as a dark band in the corresponding GMS image. Note also the substantia nigra pars reticulata (SNR) reaching across the crus cerebri toward the SNC. The ratio image (WMS/GMS) of the two images in the second row yields the color-coded ratio image displayed on the bottom. All black and white images are shown using a standard display of 256 gray levels. The color image uses a 256-pseudocolor lookup table.fig 2. Ratio images of the cerebral peduncle displayed in pseudocolors show the morphologic characteristics of the SNC in two control participants (C1 and C2) and the structural changes in two patients with Parkinson's disease (P1 and P2). The substantia nigra pars reticulata (SNR) is indicated for participant C1. Notice that the SNC in control participants reaches out toward the peduncular edge in the upper section, taking on the form of an arch. In the images of patient P1, who has Parkinson's disease, thinning and loss of signal can be seen in the lateral segment of the SNC in the upper section. The lower section shows islands of cell loss on both sides of the SNC. Note the considerable thinning and loss of signal in both upper and lower sections of the images of patient P2, who has late-stage Parkinson's disease. Left and right sides show two rims of preserved signal
<sc>fig</sc> 3.
fig 3.
Radiologic indices are displayed for the six control participants and the six patients with Parkinson's disease. There is no overlap between the groups, which are distinct by Student's t test (P < .00005). The error bars represent one SD.fig 4. Unified Parkinson's Disease Rating Scale scores for the six patients ranging from 12 to 71 are plotted versus radiologic indices. A linear regression analysis was conducted, yielding a linear correlation coefficient of r = 0.99

References

    1. Duvoisin RC. Familial Parkinson's disease. Neurosci News 1998;1:43-46
    1. Barkats M, Bilang-Bleuel A, Buc-Caron MH, et al. Adenovirus in the brain: recent advances in gene therapy for neurodegenerative diseases. Prog Neurobiol 1998;55:333-341 - PubMed
    1. Freese A. Restorative gene therapy approaches to Parkinson's disease. Med Clin North Am 1999;83:537-548 - PubMed
    1. Fahn S, Elton ER. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Press; 1987:293-304
    1. Brooks DJ. Motor disturbance and brain functional imaging in Parkinson's disease. Eur Neurol 1997;38[suppl]:26-32 - PubMed

Publication types